Proscia has landed a network-wide customer. Unilabs, the European diagnostics group, will run Concentriq as its pathology platform across a network of more than 350 pathology experts and 400 laboratory technicians.
Roughly 9 million tissue sections pass through the network each year. Routine diagnostic case review already runs on Concentriq AP-Dx at several Unilabs sites, and more countries go live before 2026 ends.
The advantage is geographic. Concentriq centralizes distributed teams, laboratory sites, diagnostic data and AI applications inside a single enterprise environment, so subspecialty expertise no longer stays trapped at one hospital. Affiliated institutions across Europe can consult the wider network rather than shipping slides or outsourcing reads.
The architecture also aims to make AI adoptable at scale. Proscia built interoperability designed to help pathologists fold applications into daily practice as diagnostics shift toward image-based companion tests.
Badhri Srinivasan, group CEO of Unilabs, framed the rollout as a way to turn the uncertainty behind every test into clarity for patients, and to amplify expertise the network already holds.
Digital pathology has moved from pilot projects to operational infrastructure in Europe. That favors vendors whose software can sit beneath many laboratories at once instead of a single department, a position Unilabs now gives Proscia at meaningful scale.
